Key facts
- It has raised $14.0M across 1 recorded rounds; the latest was Accelerator/Incubator in Mar 2025.
- Notable investors include Springboard Enterprises, Innovation Authority, Arben Ventures, Vertex Ventures Israel, 8200 EISP — 10 tracked in total.
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Feminai
Funding rounds
1 roundsAbout Feminai
Developer of a wearable medical breast cancer screening device designed to provide an efficient and safe means to detect early cancer. The company's device provides personalized medicine, a technological edge, artificial intelligence-based medical screening and a cancer defense mechanism, enabling women to improve their chances of detecting breast cancer.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2023
- Employees
- 8
- Website
- feminai.com/
- Ownership
- Privately Held (backing)
Feminai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Feminai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Feminai in its N-PORT filings yet. We sweep new filings monthly.